Can-Fite Biopharma (CANF) Stock Leapt 90% In Premarket Session. Why?
Can-Fite BioPharma Ltd. (NYSE: CANF) stock is on an upward trend in the premarket session this morning. During pre-hour trades, Can-Fite stock gained $1.86 or 91.18% buoying at $3.90. The surge in CANF stock price is due to an exclusive distribution agreement CANF has signed with a European distributor. Get the hottest stocks to trade […]